E-PHARMACY IMPACTS ON SOCIETY AND PHARMA SECTOR IN ECONOMICAL PANDEMIC SITUATION: A REVIEW
Abstract
Four month ago, nobody knows about covid-19 but now this virus has spread to almost every country, infecting at least 3,062515 people and death approx 211449 people with badly impact on economies of the most countries and also broken their health-care systems. At this time covid-19 disease is almost spreading all over the world and society. Majorly Pharmacy services act as a pillar at this pandemic situation for the public health. China is the first country where covid-19 outbreak started and some current data of consumer behavior and their habits are showed that society take some safe and preventive measures during lockdown and social distancing time which increase growth of ecommerce demand is inevitable. Now a day’s e-pharmacy is being adapted because medications can be ordered in a one click and conveniently delivered to customer door step with some risk like misuse of drugs and self-medication especially for those drugs which comes under the schedule H and X. This review paper focus on the basic issues and challenges related to online pharmacy and how can it be beneficial to society and pharma sectors in the pandemic situation.
Keywords: Online Pharmacy, Internet, Corona virus, Pandemic situation, Pharmaceutical sector.
Downloads
References
2. Dadha P. Indian Pharma Set to Target Consumer Online - Health Files, 2015. Available at: http://www.health.economictimes.indiatimes.com/health-files/indian-pharma-set-to-target-consumer-online/721.
3. Desai C, “Online pharmacies: A boon or bane?” IJP, 2016; 48(6):615–616.
4. Ramesh B, Rao CN, Joshi V. Online Medicine Sales: Are you Aware?; Article, 2015. Available at: http://www.pharmabiz.com/PrintArticle.aspx?aid=90368&sid=9.
5. Chordiya SV, Garge BM, “E-pharmacy vs conventional pharmacy” IJCAAP, 2018; 3(4):121-123.
6. Alamelu R, Amudha R, Cresenta S, Nalini R, “Online Pharma Retail Is A Promising/Unpromising Avenue: An Indian Context” AJPCR, 2016; 9(2): 26-29.
7. Prashanti G, Sravan S, Noorie S, “A Review on Online Pharmacy” IOSR-IPBS, 2017; 12(3):32-34.
8. Nair SP, Middha A, “Ideas and Innovations in Technology” IJAR, 2019; 5(1):1-4.
9. Liu S, Luo P, Tang M, Hu Q, Polidoro JP, Sun S et al. “Providing pharmacy services during the coronavirus pandemic” Int J Clin Pharm, 2020; 42(2): 299-304.
10. Purva S, Ashwini D, “Vigilance for Sale of Drugs through Online Pharmacies” Adv Case Stud, AICS, 2018; 1(3):000511.
11. Mohd A, Mustfa M, “Consumer buying behavior of retail pharmacy industry with special references to Delhi and NCR” IJMSEM, 2017; 2(4):1-17.
12. Jain VH, Tadvi SA, Pawar SP, “A review on the pros and cons of online pharmacies” JAPR, 2017; 5 (1):20 -26.
13. David M, “Cybermedicine: the benefits and risks of purchasing drugs over the internet” JTLP, 2000; 5 (2):1.
14. Karnati N, Vishnu P, Kommu V, Sharma Jvc, “Regulations of e-pharmacy in India” WJPR, 2019;8:421-430.
15. Jain NK. A Text book of Forensic Pharmacy. 7th ed. Delhi: Vallabh Prakashan 2007; 184: 49-54.
16. Priyanka VP, “E-pharmacies regulation in India: Bringining new Dimensions to pharma sector” Pharmaceutical Regulatory Affairs, 2016; 5(2): 15-21.
17. Crawford SY, “Internet pharmacy: issues of access, quality, costs, and regulation” J MED SYST, 2003; 27(1):57-65.
18. Singh R, “Should E-Pharmacy be made Illegal in India?” JMC, 2019; 5(1):18-22.
19. Anatani M, Shukla A. “Online Pharmacies. Indian online pharmacies and drug stores in legal tug-of-war” EHLP, 2015.
20. Thalkari AB, Karwa PN, Gwali CS, “A Review on Online Pharmacy: Views and Counterviews” AJPT, 2018; 8 (2):108-111.
21. E-Pharmacy Market by Drug Type (Prescription Drugs and Over The Counter Drugs): Global Industry Perspective, Comprehensive Analysis, and Forecast 2018–2025, Zion market research; Available at: https://www.zionmarketresearch.com/requestbrochure/e-pharmacy-market Accessed June 18 2019.
22. Top online pharmacies startup: Tracxon Article, 2019. Available at: https://tracxn.com/d/trending-themes/Startups-in-Online-Pharmacies Accessed 04 December 2019.
23. Alamelu R, Motha CS, Amudha R, Badrinath V, “Pharmaceutical Industry- Studious or spurious? - An Indian Context” RJPBCS, 2015; 6(5): 847-853.
24. Dadhich A, The COVID-19 pandemic and the Indian pharmaceutical industry, Article, 2020. Available at: https://www.europeanpharmaceuticalreview.com/article/117413/the-covid-19-pandemic-and-the-indian-pharmaceutical-industry/ Accessed 22 April 2020.
25. Malvern J, Drug runners keep medicines moving during lockdown, Article, 2020. Available at: https://www.thetimes.co.uk/article/drug-runners-keep-medicines-moving-during-lockdown-5khm9lxxj accessed April 2020
26. Chatterjee P, “Indian pharma threatened by COVID-19 shutdowns in China” Lancet, 2020; 395(10225):675.
27. Thacker T. Covid-19 impact: Government panel lists essential drugs that can run out, 2020 Available at : https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-impact-government-panel-lists-essential-drugs-that-can-run out/articleshow/74449944.cms?from=mdr Accessed 03 March 2020.
28. Theodore JC, Matthew SE, “Health Outcomes in Patients Using No-Prescription Online Pharmacies to Purchase Prescription Drugs” J Med Internet Res, 2012; 14(6):174.
29. Mackey TK, Liang BA, “Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health” Globalization and Health, 2010; 9:45.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).